arrow
F

Federico Quadrelli

IRCCS Azienda Ospedaliero-Universitaria di Bologna
H指数:6
被引数:102

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Baricitinib versus ritlecitinib for severe alopecia areata: A 24-week real-world study
2026-09-010
PRE
Relapse of Alopecia Areata During Ongoing JAK Inhibitor Therapy Is Not Uncommon and Usually Occurs in Previously Affected Areas: A Multicentre Italian Real-World Study.

斑秃在JAK抑制剂治疗期间复发并不罕见,且通常发生在先前受影响的区域:一项多中心意大利真实世界研究。

2026-08-130
OA
Phototype-related Trichoscopic differences in lichen Planopilaris and frontal Fibrosing alopecia

光型相关的镜下差异在扁平苔藓和前额纤维性脱发中的应用

2026-07-290
PRE
Trichoscopy of Cicatricial Alopecia in Fair and Dark Skin: A Multicenter International Study of the EADV Task Force on Hair Diseases and the IDS Task Force on Trichoscopy

瘢痕性脱发在肤色较浅和肤色较深人群中的毛发镜检查:欧洲皮肤与性病学会联盟毛发疾病工作组与印度皮肤科协会毛发镜检查工作组的跨国多中心研究

2026-05-010
PRE
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results

巴瑞替尼在严重斑秃中的有效性与安全性:48周结果

2025-09-230
PRE
Nail toxicities associated with cancer therapies: Insights and recommendations from the EADV task force dermatology for cancer patients

癌症治疗相关的指甲毒性:EADV肿瘤患者皮肤病学工作组的心得与建议

2025-09-090
PRE
Defining Predictive Factors for Permanent Chemotherapy-Induced Alopecia: Trichoscopy, Reflectance Confocal Microscopy and Histopathology Study on 77 Patients
2025-03-010
OAAI
Erosive pustular dermatosis of the scalp due to EGFR inhibitors: A multicentric study by EADV task force of 'Dermatology for Cancer Patients'

头皮侵蚀性脓疱性皮病与EGFR抑制剂相关:EADV“肿瘤患者皮肤病学”工作组的多中心研究

2025-02-030
PRE
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study
2024-09-090
PRE